- Home
- NPO vs SRRK Comparison
NPO vs SRRK Comparison
Compare NPO & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NPO | SRRK |
|---|---|---|
| Founded | 2002 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.6B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | NPO | SRRK |
|---|---|---|
| Price | $224.94 | $45.94 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 9 |
| Target Price | ★ $243.33 | $47.88 |
| AVG Volume (30 Days) | 186.7K | ★ 1.5M |
| Earning Date | 11-04-2025 | 11-14-2025 |
| Dividend Yield | ★ 0.57% | N/A |
| EPS Growth | ★ 58.40 | N/A |
| EPS | ★ 4.06 | N/A |
| Revenue | ★ $1,106,300,000.00 | N/A |
| Revenue This Year | $8.71 | N/A |
| Revenue Next Year | $9.74 | $20,271.77 |
| P/E Ratio | $53.86 | ★ N/A |
| Revenue Growth | ★ 6.44 | N/A |
| 52 Week Low | $133.50 | $22.71 |
| 52 Week High | $248.88 | $48.28 |
Technical Indicators
Market Signals| Indicator | NPO | SRRK |
|---|---|---|
| Relative Strength Index (RSI) | 56.45 | 63.42 |
| Support Level | $204.25 | $42.61 |
| Resistance Level | $225.51 | $45.32 |
| Average True Range (ATR) | 7.30 | 2.02 |
| MACD | 0.06 | -0.36 |
| Stochastic Oscillator | 86.06 | 60.51 |
Price Performance
Historical ComparisonAbout NPO Enpro Inc.
Enpro Inc formerly EnPro Industries Inc is a United States-based company that designs, develops, manufactures, and markets proprietary engineered industrial products. The company operates through three segments: Sealing Technologies, which derives maximum revenue, manufactures and markets sealing products, wheel-end components & systems; and Advanced Surface Technologies manufactures wafer processing sub-systems, thin-film coatings, optical filters, and other services like cleaning, coating, testing, and refurbishment. Its geographical segments are the United States, Europe, and other foreign countries.
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.